LB Pharmaceuticals grants SVP Zergebel option for 75,000 shares at $32.95 under Nasdaq inducement rule - LBRX News | RalliesLB Pharmaceuticals grants SVP Zergebel option for 75,000 shares at $32.95 under Nasdaq inducement rule
L
LBRX• Inducement stock option grant
- LB Pharmaceuticals granted new SVP Clinical Operations Christopher Zergebel a stock option for 75,000 shares on July 10, 2026.
- Option term is 10 years. Exercise price is $32.95 per share, set at the closing price on the grant date.
- Award vests over four years: 25% after one year, then 1/48 monthly, subject to continued service.
